SAN

82.08

+1.41%↑

SHL.DE

42.36

+0.19%↑

PHIA

27.11

+0.82%↑

SRT3

239.4

+0.59%↑

ORNBV.FI

67.7

0%↓

SAN

82.08

+1.41%↑

SHL.DE

42.36

+0.19%↑

PHIA

27.11

+0.82%↑

SRT3

239.4

+0.59%↑

ORNBV.FI

67.7

0%↓

SAN

82.08

+1.41%↑

SHL.DE

42.36

+0.19%↑

PHIA

27.11

+0.82%↑

SRT3

239.4

+0.59%↑

ORNBV.FI

67.7

0%↓

SAN

82.08

+1.41%↑

SHL.DE

42.36

+0.19%↑

PHIA

27.11

+0.82%↑

SRT3

239.4

+0.59%↑

ORNBV.FI

67.7

0%↓

SAN

82.08

+1.41%↑

SHL.DE

42.36

+0.19%↑

PHIA

27.11

+0.82%↑

SRT3

239.4

+0.59%↑

ORNBV.FI

67.7

0%↓

Home・Akcijų sąrašas・Nanobiotix

N
Nanobiotix

Uždarymo kaina

25.55 11.33

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

23.1

Max

25.6

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-5.4M
Pardavimai	27M
Pelno marža	-20.208
Darbuotojai	103
EBITDA	1.1M

Rekomendacijos
By TipRanks
Rekomendacijos	Pirkti
12 mėnesių prognozė	+0.22% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-04-01

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	1B
Ankstesnė atidarymo kaina	14.22
Ankstesnė uždarymo kaina	25.55

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bullish Evidence

2.975 / 3.015 Palaikymas ir pasipriešinimas

Nanobiotix Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-27 23:53; UTC

Karštos akcijos

Stocks to Watch: Aardvark Therapeutics, Blue Moon Metals

2026-02-27 22:23; UTC

Įsigijimai, susijungimai, perėmimai

Blue Moon Metals To Acquire Apex Germanium Mine From Teck Subsidiary

2026-02-27 17:55; UTC

Karštos akcijos

Toronto Stocks Decline, But Remain On Track for Weekly Gains

2026-02-27 23:46; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Walks Away a Winner After Losing Warner Bros. to Paramount -- Barrons.com

2026-02-27 23:33; UTC

Įsigijimai, susijungimai, perėmimai

Paramount Issuing $47 Billion of Equity at Nearly 20% Premium to Current Stock Price -- Barrons.com

2026-02-27 21:50; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Tech, Media & Telecom Roundup: Market Talk

2026-02-27 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-02-27 21:30; UTC

Uždarbis

Solventum Beat Wall Street Earnings Estimates. The Stock Falls. -- Barrons.com

2026-02-27 21:30; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Warner Terminates Netflix Deal, Ending Monthslong Saga -- Market Talk

2026-02-27 21:20; UTC

Įsigijimai, susijungimai, perėmimai

Blue Moon Metals to Buy Apex Germanium and Gallium Mine From Teck >BMM

2026-02-27 21:17; UTC

Uždarbis

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

2026-02-27 21:10; UTC

Įsigijimai, susijungimai, perėmimai

Blue Moon Metals Evaluating Options for a New Processing Line at Springer Complex to Process the Apex Material

2026-02-27 21:09; UTC

Įsigijimai, susijungimai, perėmimai

Blue Moon Metals to Acquire the Apex Germanium and Gallium Mine From Teck

2026-02-27 21:00; UTC

Uždarbis

Nike: 3Q Results to Be Released March 31 to Accommodate for Several Holidays >NKE

2026-02-27 20:31; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Receives $2.8B Termination Fee Under Terminated Warner Bros. Discovery Deal

2026-02-27 20:24; UTC

Rinkos pokalbiai

Oil Gains on Increased Risk of U.S.-Iran Conflict -- Market Talk

2026-02-27 20:23; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Post Modest Gains -- Market Talk

2026-02-27 20:12; UTC

Rinkos pokalbiai

Nike Seen With Further Challenges in China -- Market Talk

2026-02-27 19:44; UTC

Rinkos pokalbiai

Gold Caps Historic Month -- Market Talk

2026-02-27 19:39; UTC

Uždarbis

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

2026-02-27 19:38; UTC

Uždarbis

Earnings Could Push the Stock Market Higher. Too Bad About Everything Else. -- Barrons.com

2026-02-27 18:53; UTC

Įsigijimai, susijungimai, perėmimai

Largest U.S. Pension Takes Stake in a Hot Semi Stock, Buys More Nvidia and IonQ -- Barrons.com

2026-02-27 18:45; UTC

Uždarbis

Quantum Computing Is No Longer a Speculative Bet. IonQ's Surging Stock Drives Home That Point. -- Barrons.com

2026-02-27 18:45; UTC

Rinkos pokalbiai

Bitcoin Stays Vulnerable in Choppy Geopolitical Situation -- Market Talk

2026-02-27 17:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-02-27 17:07; UTC

Uždarbis

Pemex Cuts 4Q Loss As Operating Results Improve

2026-02-27 17:00; UTC

Rinkos pokalbiai

Corn Rides Oil Momentum Higher -- Market Talk

2026-02-27 16:31; UTC

Rinkos pokalbiai

Canadian Economy Shows Resilience -- Market Talk

2026-02-27 16:17; UTC

Rinkos pokalbiai

Canada Economy is Struggling But More Rate Cuts Still a Long Shot -- Market Talk

2026-02-27 15:49; UTC

Uždarbis

Quantum Computing No Longer a Speculative Bet. IonQ's Surging Stock Drives Home That Point. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Nanobiotix Prognozė

Kainos tikslas

By TipRanks

0.22% į viršų

12 mėnesių prognozė

Vidutinis 23 EUR 0.22%

Aukščiausias 23 EUR

Žemiausias 23 EUR

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Nanobiotix kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

1 ratings

Pirkti

Laikyti

Parduoti

Remiantis 1 analitikų, pateikusių Nanobiotix akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

2.975 / 3.015Palaikymas ir pasipriešinimas

Recent bullish events outweigh bearish events.

Bearish events outweigh bullish events.

There is one bearish event.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Nanobiotix

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.